Brief: Immunocore Announces Dosing Of First Patient With ImmTAV Bispecific For HIV

Immunocore Holdings

11/07/2022 12:37

July 11 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE ANNOUNCES DOSING OF FIRST PATIENT WITH IMMTAV®
BISPECIFIC FOR HIV

Source text for Eikon:  ID:nGNX1Jm6q9 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))